Regulatory News
Tuesday, September 20, 2016
Regeneron, Teva take aim at Lilly/Pfizer pain drug
Sept 20 (Reuters) - Regeneron Pharmaceuticals Inc
and Israeli drugmaker Teva Pharmaceutical Industries
on Tuesday said they would co-develop Regeneron's experimental
new type of pain drug and...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment